Overview

Comparison of Two Liraglutide Formulations in Healthy Volunteers

Status:
Completed
Trial end date:
2004-06-30
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to test for bioequivalence of two formulations of liraglutide.
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Liraglutide